Renalytix plc (RNLXY): Weighted Average Diluted Shares
Not updated since 2024-06-30. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
108.18M
Year ended 2024-06-30
+14.8%
3-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2024-06-30 | 108.18M | +31.6% | 2024-09-30, From 2023-07-01 |
| 2023-06-30 | 82.21M | +11.3% | 2024-09-30, From 2022-07-01 |
| 2022-06-30 | 73.84M | +3.3% | 2023-09-28, From 2021-07-01 |
| 2021-06-30 | 71.48M | +21.0% | 2022-10-31, From 2020-07-01 |
| 2020-06-30 | 59.08M | n/a | 2022-10-31, From 2019-07-01 |